Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen With or Without Fenretinide in Postmenopausal Women With Breast Cancer
NCT00002646Phase 3Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Oct 1995
- Primary completion
- Feb 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in breast cancer comparing Tamoxifen + Fenretinide with Tamoxifen + Placebo (2 arms). Primary endpoints: Disease-Free Survival and Overall Survival. Started Oct 1995; status: completed.
02
Drugs
fenretinide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00002646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002646.